REG-Proven VCT plc : Appointment of Chairman

Proven VctAnnouncement

10/05/2018 10:35

2018-05-10T09:32:13.642Zreuters.comtag:reuters.com,2018-05-10:newsml_GNE1dVssG:13TXT
(c) Copyright GlobeNewswire, Inc. 2018This file is provided for EAP sample purposes only; it's structure and detail are subject to change, and should not be used as a definitive reference for actual development and processing.2018-05-10T09:32:13.642Z2018-05-10T09:32:13.642ZUCDP:parsn_hugin_10.54.132.131_1.2.37235:2019-06-10T09:32:13.642Z3GNE1dVssGREG-Proven VCT plc : Appointment of ChairmanLEGACY: Financials (TRBC)LEGACY: Banking & Investment Services (TRBC)LEGACY: Investment Banking & Investment Services (TRBC)Venture Capital (TRBC level 5)Investment Management & Fund Operators (TRBC level 4)Financials (TRBC level 1)Banking & Investment Services (TRBC level 2)Investment Banking & Investment Services (TRBC level 3)Western EuropeUnited KingdomEuropeSuggested SourcesServicesNews AnnouncementsRegulatory Corporate News AnnouncementsCompany NewsProven Vct PLC




  
ProVen VCT plc
 
Appointment of Chairman
 
10 May 2018
 
ProVen VCT plc (the "Company") is pleased to announce that Neal Ransome, an existing non-executive Director of the Company, will become Chairman following the Company's forthcoming Annual General Meeting scheduled for 11 July 2018.
 
Neal joined the Board in October 2017 and brings with him a great deal of knowledge and experience. Neal is a chartered accountant and was a former Partner at PwC, where he was Chief Operating Officer of PwC's Advisory business and led its Pharmaceutical and Healthcare Corporate Finance practice. Neal is also a director of Octopus AIM VCT plc and Polar Capital Global Healthcare Trust plc.
 
Neal succeeds Andrew Davison, who has been a Director since 2000 and who will retire as Chairman and Director following the Company's forthcoming Annual General Meeting. 
 
The Company would like to thank Andrew for his significant contribution during his tenure as Director and Chairman.
 
Beringea LLP
 Company Secretary
 Telephone 020 7845 7820
 
- End
 
 
 
 
 


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Proven VCT plc via Globenewswire